KalVista Pharmaceuticals, Inc. (KALV)

14.84 -1.06 (-6.67%) USD  |  NASDAQ  |  Dec 17, 15:06
More

KalVista Pharmaceuticals Annual EPS GAAP Estimates

Annual EPS GAAP Estimates Chart

View Annual EPS GAAP Estimates for KALV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual EPS GAAP Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual EPS GAAP Estimates Range, Past 5 Years

View Annual EPS GAAP Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual EPS GAAP Estimates Benchmarks

View Annual EPS GAAP Estimates Benchmarks
Start Trial
BioCryst Pharmaceuticals, Inc. Upgrade
Iovance Biotherapeutics, Inc. Upgrade
Travere Therapeutics, Inc. Upgrade
Xenetic Biosciences, Inc. Upgrade
BeyondSpring, Inc. Upgrade